Stanley Center for Psychiatric Research

Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard

Stanley Center Scientific Investigators are successfully working on these issues in highly collaborative teams to significantly advance our knowledge of psychiatric disease and the development of treatments. Additionally, the Stanley Center launched the Stanley Global  Neuropsychiatric Genetics Initiative (Stanley Global) in 2014, collaborating with research groups around the world to expand genetic sample collection across diverse worldwide populations.

Find out more about our areas of focus:

  1. Human genetics initiatives
  2. Methods and tool development
  3. Neurobiology initiatives
  4. Therapeutics and biomarker discovery

Through research at the Broad Institute and partnerships with collaborators worldwide, scientists at the Stanley Center aim to develop diagnostics and treatments to help people with mental health conditions. Our research informs our understanding of the biology of psychiatric disorders, neurodevelopmental conditions, and neurodegenerative disorders including schizophrenia, bipolar disorder, autism spectrum disorders, ADHD, and Alzheimer’s.

Click here to read the Stanley Center's Commitment to Genomic Data Sharing

Philanthropists Ted and Vada Stanley enabled this groundbreaking research. In 2014, Stanley announced an unprecedented commitment of $650 million aimed at galvanizing scientific research on psychiatric disorders and bringing new treatments based on molecular understanding to hundreds of millions of people around the world.

In total, the Stanley Family Foundation’s philanthropy in support of the Stanley Center totals $860 million. The gifts from the Stanley Family Foundation represent the largest philanthropic commitment ever in psychiatric research and stand among the largest for scientific research in general.